← Product Code [EBI](/productcode/EBI) · K261474 # DENTCA Tru Flexible (K261474) _Dentca, Inc. · EBI · Jul 1, 2026 · Dental · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K261474 ## Device Facts - **Applicant:** Dentca, Inc. - **Product Code:** [EBI](/productcode/EBI.md) - **Decision Date:** Jul 1, 2026 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.3760 - **Device Class:** Class 2 - **Review Panel:** Dental - **Attributes:** Therapeutic ## Indications for Use DENTCA Tru Flexible is a light-curable resin indicated for the fabrication of removable flexible full and partial denture bases in dental laboratories or dental office. The material is also indicated for fabrication of try-in dentures for clinical evaluation and as an aid for bonding denture teeth to denture bases. ## Device Story DENTCA Tru Flexible is a light-curable, methacrylate-based resin used for additive manufacturing (3D printing) of removable flexible full and partial denture bases. Operated by dental professionals in laboratories or offices, the material is processed via CAD/CAM systems; it involves automated layer-by-layer printing followed by light-curing. The device serves as an alternative to traditional heat-cured or auto-polymerizing resins. It is also used for fabricating try-in dentures and bonding printed teeth to denture bases. The output is a custom-fit dental prosthetic base. Clinical benefit includes efficient, automated production of flexible, biocompatible dental appliances. ## Clinical Evidence Bench testing only. Performance testing conducted per ISO 20795-1:2013, including ultimate flexural strength, maximum stress intensity factor, total fracture work, color stability, porosity, bonding to polymer teeth, water sorption, water solubility, and printing accuracy. Biocompatibility testing performed per ISO 7405:2018 and ISO 10993-1. ## Technological Characteristics Type 4 light-cure methacrylate-based resin containing photoinitiators and pigments. Fabrication via additive 3D printing and light-curing. Complies with ISO 20795-1:2013. Biocompatibility per ISO 7405:2018 and ISO 10993-1. ## Regulatory Identification A denture relining, repairing, or rebasing resin is a device composed of materials such as methylmethacrylate, intended to reline a denture surface that contacts tissue, to repair a fractured denture, or to form a new denture base. This device is not available for over-the-counter (OTC) use. ## Predicate Devices - Apex Flex ([K250617](/device/K250617.md)) ## Reference Devices - DENTCA Base Hi-Impact ([K220042](/device/K220042.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} FDA U.S. FOOD & DRUG ADMINISTRATION July 1, 2026 Dentca, Inc. Jason Lee Official Correspondent 17742 Cowan Irvine, California 92614 Re: K261474 Trade/Device Name: DENTCA Tru Flexible Regulation Number: 21 CFR 872.3760 Regulation Name: Denture Relining, Repairing, Or Rebasing Resin Regulatory Class: Class II Product Code: EBI Dated: May 4, 2026 Received: May 4, 2026 Dear Jason Lee: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K261474 - Jason Lee Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory- {2} K261474 - Jason Lee Page 3 assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, # MICHAEL E. ADJODHA -S Michael E. Adjodha, MChE, RAC, CQIA Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration # **Indications for Use** Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below. 510(k) Number (if known) K261474 Device Name DENTCA Tru Flexible Indications for Use (Describe) DENTCA Tru Flexible is a light-curable resin indicated for the fabrication of removable flexible full and partial denture bases in dental laboratories or dental office. The material is also indicated for fabrication of try-in dentures for clinical evaluation and as an aid for bonding denture teeth to denture bases. Type of Use (Select one or both, as applicable) ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) **CONTINUE ON A SEPARATE PAGE IF NEEDED.** This section applies only to requirements of the Paperwork Reduction Act of 1995. **\*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*** The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov *"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."* FORM FDA 3881 (6/20) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF {4} K261474 # 510(k) Summary ## Submitter DENTCA, INC. 17742 Cowan, Irvine, CA 92614 Phone: 855-933-6822 Fax: 424-558-8738 Contact Person: Jason Lee Date Prepared: December 15, 2025 ## Device Classification | Proprietary Name: | DENTCA Tru Flexible | | --- | --- | | Trade Name: | DENTCA Tru Flexible | | Common Name: | Dental Acrylic Resin | | Classification Name: | Denture relining, repairing, or rebasing resin | | Regulation Number: | 21 CFR 872.3760 | | Product Code: | EBI | | Regulatory Class: | II | | Review Panel: | Dental | ## Predicate Device The following predicate is a legally marketed, post-amendment device: | 510(k) Number: | K250617 | | --- | --- | | Clearance Date: | April 29, 2025 | | Trade Name: | Apex Flex | | Actual Trade Name: | Apex Flex | | Manufacturer: | SprintRay | | Regulation Number: | 21 CFR 872.3760 | | Product Code: | EBI | 1 {5} ## Reference Device The following reference is a legally marketed, post-amendment device: | 510(k) Number: | K220042 | | --- | --- | | Clearance Date: | November 17, 2022 | | Actual Trade Name: | DENTCA Base Hi-Impact | | Manufacturer: | DENTCA, Inc. | | Regulation Number: | 21 CFR 872.3760 | | Product Code: | EBI | ## Device Description DENTCA Tru Flexible is a light-curable resin intended to fabricate removable flexible dentures bases in a CAD/CAM system using an additive printing process. This material is used as an alternative to traditional heat cured and auto polymerizing denture base resins and is available in multiple shades. DENTCA Tru Flexible can also be utilized to bond printed teeth onto denture base. ## Indications For Use DENTCA Tru Flexible is a light-curable resin indicated for the fabrication of removable flexible full and partial denture bases in dental laboratories or dental office. The material is also indicated for fabrication of try-in dentures for clinical evaluation and as an aid for bonding denture teeth to denture bases. ## Comparison of Technological Characteristics With Predicate The following table compares technological and other characteristics of the subject, predicate, and reference devices. 2 {6} Table 1 Comparison of Technical Features | | Subject Device | Predicate Device | Reference Device | Similarities and Differences | | --- | --- | --- | --- | --- | | Device Names | DENTCA Tru Flexible | SprintRay Apex Flex | DENTCA Base Hi-Impact | NA | | Regulation & Product Code | 872.3760; EBI | 872.3760; EBI | 872.3760; EBI | Same Classification | | Intended Use | Fabrication of removable flexible denture bases and dental prosthesis. | Fabrication and repair of partial dentures | Fabrication and repair of base plates for removable dental prosthetic appliances | Similar Intended Use | | Indications For Use | DENTCA Tru Flexible is a light-curable resin indicated for the fabrication of removable flexible full and partial denture bases in dental laboratories or dental office. The material is also indicated for fabrication of try-in dentures for clinical evaluation and as an aid for bonding denture teeth to denture bases. | SprintRay Apex Flex is an alternative to traditional thermoplastic material used for the fabrication and repair of partial dentures. It is intended exclusively for professional dental work. | DENTCA Base Hi-Impact is a light-curable resin indicated for the fabrication and repair of removable denture bases in dental laboratories, including full and partial dentures as well as immediate dentures, and other dental appliances. DENTCA Base Hi-Impact can | Similar Indications for Use | 3 {7} | | | also be used for the fabrication of try-in dentures for the evaluation before fabricating the final dentures. Fabrication of these prosthesis with DENTCA Base Hi-Impact requires a digital denture file, additive printer, and curing light equipment. DENTCA Base Hi-Impact can be utilized as an aid in bonding the denture teeth onto denture base. | | | --- | --- | --- | --- | Device Description | Type 4, Light-cure resin | Type 4, Light-cure resin | Type 4, Light-cure resin | Same Type | | --- | --- | --- | --- | | Methacrylate-based resins with photoinitiator, and pigments | Acrylate-based resins including photoinitiator and pigments | Methacrylate-based resins with photoinitiator, and pigments | All similar chemical system. | ![img-0.jpeg](img-0.jpeg) 4 {8} | Fabrication Method of Denture Base | Automated 3D printing of resin in multiple layers, and post-cure in light curing unit | Automated 3D printing of resin in multiple layers, and post-cure in oven curing unit | Automated 3D printing of resin in multiple layers, and post-cure in light curing unit | Same technology | | --- | --- | --- | --- | --- | | Teeth Assemble | Chemical Bonding | Chemical Bonding | Chemical Bonding | Same Technology | | Requirement | Meets the specification of ISO 20795-1 for Type 4 material | Meets the specification of ISO 20795-1 for Type 4 material | Meets the specification of ISO 20795-1 | Same Standard | | Intended User | Fabricated by Dental professionals in a dental lab | Fabricated by Dental professionals in a dental lab | Fabricated by Dental professionals in a dental lab | Same User | 5 {9} The above comparison shows the similarities on indications for use and technological aspects among the devices. A comparison proved that all devices fabricate the denture bases and dental prosthesis in the same manner, via automated application of a light-cure resins in an additive 3D printer. ## Non-Clinical and/or Clinical Tests Summary The following non-clinical testing conducted and its data were provided in support of the substantial equivalence determination. ### Biocompatibility Testing The biocompatibility evaluation for DENTCA Tru Flexible was conducted in accordance with the standard ISO 7405:2018 *Dentistry – Evaluation of biocompatibility of medical devices used in dentistry* and the FDA Guidance “*Use of International Standard ISO 10993-1, Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.*” The denture base is considered tissue contacting for a period longer than 30 days (a removable prosthesis). ### Software Verification and Validation Testing The operation software for additive printing (3D printer) was verified and validated in accordance with the FDA guidance “*FDA Reviewers and Compliance on Off-The-Shelf Software Use in Medical Devices*” and “*Technical Considerations for Additive Manufactured Medical Devices.*” ### Performance Test Bench test for DENTCA Tru Flexible was conducted for conformity in accordance with ISO 20795-1:2013 *Dentistry – Base polymers – part 1: Denture base polymers*, as recognized by FDA. The battery of testing included the following tests: - ✓ Ultimate Flexural Strength 6 {10} - ✓ Maximum Stress Intensity Factor - ✓ Total Fracture Work - ✓ Color Stability - ✓ Freedom from Porosity - ✓ Bonding to Polymer Teeth - ✓ Water Sorption - ✓ Water Solubility - ✓ Printing Accuracy DENTCA Tru Flexible consistently performed as anticipated, yielding satisfactory outcomes. ## Conclusions The above comparison of the subject and predicate devices shows that both devices fabricate the denture in the same manner, via automated application of a light-curable resin in an additive 3D printer. The subject and predicate devices have the same intended use, similar indications for use, and comprise the same technological characteristics. Furthermore, the non-clinical data support the safety and effectiveness of the device and demonstrates that DENTCA Tru Flexible should perform as intended in the specified use conditions. In conclusion, DENTCA Tru Flexible is substantially equivalent to the legally marketed SprintRay Apex Flex, and thus warrants clearance from FDA for premarketing activities in the United States. 7 --- **Source:** [https://fda-staging.innolitics.com/device/K261474](https://fda-staging.innolitics.com/device/K261474) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com